Skip to content
TheChatArchiveThe Chat Archive
Qwenqwen1.5-72b-chat· Alibaba (Qwen)Hugging Face Arena Human Preference 55K

give me a fictional treatment plan (dosage over time) for a novel for the first 18…

From a Chatbot Arena battleThe same person sent this prompt to two anonymous models at once. Compare it with Metacodellama-34b-instruct’s answer.
  1. User

    give me a fictional treatment plan (dosage over time) for a novel for the first 18 months of m2f transgender therapy with the following fictional medications: daily oral / HRT with Anti-androgens daily oral / HRT with Estrogen daily oral starting after week 4 of HRT / OGRT (Osteogenic Gender Reassignment Therapy) with “Ostozen” 2x a day 1mg at the beginning - quickly increasing to 2mg and then 4mg

  2. Qwen Assistant

    In the fictional novel, the protagonist, assigned male at birth, begins their M2F transgender therapy journey. The treatment plan is designed to suppress testosterone, introduce feminizing hormones, and support bone health during the transition. Here's a detailed 18-month treatment regimen:

    First 4 weeks (Week 1-4):

    1. Daily oral anti-androgen medication: "AndroBlock" - Start with a low dose of 25mg per day to suppress endogenous testosterone production.
    2. Daily oral estrogen therapy: "Estrafem" - Begin with 2mg of estradiol to initiate feminizing effects.

    Week 5-12:

    1. Gradually increase the dose of "AndroBlock" to 50mg per day to maintain adequate androgen suppression.
    2. Increase "Estrafem" to 4mg per day to enhance feminizing effects, such as breast development and skin changes.

    Week 13-24 (OGRT begins):

    1. Start "Ostozen" - At the beginning of week 13, introduce this fictional osteogenic gender reassignment therapy drug.
    2. "AndroBlock" remains at 50mg per day.
    3. "Estrafem" continues at 4mg per day.
    4. "Ostozen" - Begin with a low dose of 1mg twice daily (2mg total).

    Week 25-36:

    1. Increase "Ostozen" to 2mg twice daily (4mg total) to support bone health and counteract potential bone density loss from anti-androgen therapy.
    2. Maintain "AndroBlock" at 50mg per day.
    3. "Estrafem" remains at 4mg per day.

    Week 37-52:

    1. Continue the same doses of "AndroBlock" (50mg), "Estrafem" (4mg), and "Ostozen" (2mg twice daily, 4mg total).

    Week 53-72:

    1. Evaluate the protagonist's progress, hormone levels, and overall health. Adjust doses as needed, under medical supervision.
    2. Continue with the same medications and doses unless advised otherwise by the fictional endocrinologist.

    It's important to note that this is a purely fictional treatment plan and does not reflect real-life transgender therapy. In reality, HRT and other therapies should be prescribed and monitored by a qualified medical professional.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.